Tess Petersen

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Anita Kohli, A. Osinusi, Zayani Sims et al. · The Lancet · 2015 · 151 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

HDAC6 Regulates Glucocorticoid Receptor Signaling in Serotonin Pathways with Critical Impact on Stress Resilience

Julie Espallergues, Sarah L. Teegarden, Avin Veerakumar et al. · Journal of Neuroscience · 2012 · 144 citations · Full text

Medicine, Neurobiology, Neuroscience +17

High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study

Tess Petersen, Kerry Townsend, Lori A. Gordon et al. · Hepatology International · 2015 · 66 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +14

Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine

Kimberly Y. Smith, C. Tierney, Katie R. Mollan et al. · Clinical Infectious Diseases · 2013 · 33 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir

Kerry Townsend, Tess Petersen, Lori A Gordon et al. · AIDS · 2015 · 26 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15